Tentative Approval — This application has been tentatively approved by the FDA but is not yet listed in the Orange Book. It is blocked from final approval by unexpired patents or exclusivities on the reference listed drug.
CARFILZOMIB | A209526 | MSN PHARMACEUTICALS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Onyx Therapeutics, Inc. v. MSN Pharmaceuticals, Inc. et al 10 patentsANDA 209526carfilzomib | D. Del. | 2017-12-20 | Terminated 2019-05-08 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
No patent or exclusivity listings for this strength.